72694 Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 

organization is allowed one time slot. At 

least 7 minutes will be allotted to each 

time slot, and if time permits, may be 

extended to 10 minutes at the discretion 

of the chair. 

Persons wishing to make an oral 

presentation are asked to register online 

at http://ntp.niehs.nih.gov/go/730864 by 

May 4, 2015, and indicate whether they 

will present comments in-person or via 

the teleconference line. If possible, oral 

public commenters should send a copy 

of their slides and/or statement or 

talking points at that time. Written 

statements can supplement and may 

expand the oral presentation. 

Registration for in-person oral 

comments will also be available at the 

meeting, although time allowed for 

presentation by on-site registrants may 

be less than that for registered speakers 

and will be determined by the number 

of speakers who register on-site. 

Background Information on NTP and 

ODS: The NTP is an interagency 

program, established in 1978 (43 FR 

53060) and headquartered at the 

National Institute of Environmental 

Health Sciences (NIEHS) of the National 

Institutes of Health (NIH). The mission 

of NTP is to evaluate agents of public 

health concern by developing and 

applying tools of modern toxicology and 

molecular biology. The NTP carries out 

literature analysis activities in the Office 

of Health Assessment and Translation 

and the Office of the Reports on 

Carcinogens. The NTP also designs and 

conducts laboratory studies and testing 

programs and analyzes its findings to 

assess potential hazards to human 

health from exposure to environmental 

substances, including dietary 

supplements (see http://ntp.niehs.nih.

gov/). 

The mission of the ODS of the NIH is 

to strengthen knowledge and 

understanding of dietary supplements 

by evaluating scientific information, 

stimulating and supporting research, 

disseminating research results, and 

educating the public to foster an 

enhanced quality of life and health for 

the population of the United States. The 

purpose and responsibilities of the ODS 

are to explore more fully the potential 

role of dietary supplements as a 

significant part of the efforts of the 

United States to improve health care; to 

promote scientific study of the benefits 

of dietary supplements in maintaining 

health and preventing chronic disease 

and other health-related conditions; to 

conduct and coordinate scientific 

research within NIH relating to dietary 

supplements; to collect and compile the 

results of scientific research relating to 

dietary supplements, including 

scientific data from foreign sources; and 

to serve as the principal advisor to the 

Secretary of the Department of Health 

and Human Services and the Assistant 

Secretary for Health and to provide 

advice on issues relating to dietary 

supplements to the Director of NIH, the 

Director of the Centers for Disease 

Control and Prevention, and the 

Commissioner of the Food and Drug 

Administration (see http://ods.od.nih.

gov/). The Dietary Supplement Health 

and Education Act of 1994 (Pub. L. 103– 

417, DSHEA) authorized the 

establishment of the ODS at the NIH in 

1995. 

Background Information on NTP 

Expert Panels: NTP panels are technical, 

scientific advisory bodies established on 

an ‘‘as needed’’ basis to provide 

independent scientific peer review and 

advise the NTP on agents of public 

health concern, new/revised 

toxicological test methods, or other 

issues. These panels help ensure 

transparent, unbiased, and scientifically 

rigorous input to the program for its use 

in making credible decisions about 

human hazard, setting research and 

testing priorities, and providing 

information to regulatory agencies about 

alternative methods for toxicity 

screening. The NTP welcomes 

nominations of scientific experts for 

upcoming panels. Scientists interested 

in serving on an NTP panel should 

provide current curriculum vitae to the 

FOR FURTHER INFORMATION CONTACT. The 

authority for NTP panels is provided by 

42 U.S.C. 217a; section 222 of the Public 

Health Service (PHS) Act, as amended. 

The panel is governed by the Federal 

Advisory Committee Act, as amended (5 

U.S.C. Appendix 2), which sets forth 

standards for the formation and use of 

advisory committees. 

Dated: December 2, 2014. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2014–28681 Filed 12–5–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Institute on Deafness and 

Other Communication Disorders; 

Notice of Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended (5 U.S.C. App.), notice is 

hereby given of a meeting of the 

National Deafness and Other 

Communication Disorders Advisory 

Council. 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. 

The meeting will be closed to the 

public in accordance with the 

provisions set forth in sections 

552b(c)(4) and 552b(c)(6), Title 5 U.S.C., 

as amended. The grant applications and 

the discussions could disclose 

confidential trade secrets or commercial 

property such as patentable material, 

and personal information concerning 

individuals associated with the grant 

applications, the disclosure of which 

would constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Deafness and 

Other Communication Disorders Advisory 

Council. 

Date: January 30, 2015. 

Closed: 8:30 a.m. to 10:00 a.m. 

Agenda: To review and evaluate grant 

applications. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Open: 10:00 a.m. to 2:00 p.m. 

Agenda: Staff reports on divisional, 

programmatic, and special activities. 

Place: National Institutes of Health, 

Building 31, Conference Room 6, 31 Center 

Drive, Bethesda, MD 20892. 

Contact Person: Craig A. Jordan, Ph.D., 

Director, Division of Extramural Activities, 

NIDCD, NIH, Room 8345, MSC 9670, 6001 

Executive Blvd., Bethesda, MD 20892–9670, 

301–496–8693, jordanc@nidcd.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NIH campus. All visitor vehicles, 

including taxicabs, hotel, and airport shuttles 

will be inspected before being allowed on 

campus. Visitors will be asked to show one 

form of identification (for example, a 

government-issued photo ID, driver’s license, 

or passport) and to state the purpose of their 

visit. 

Information is also available on the 

Institute’s/Center’s home page: http:// 

www.nidcd.nih.gov/about/Pages/AdvisoryGroups-and-Review-Committees.aspx, where 

an agenda and any additional information for 

the meeting will be posted when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.173, Biological Research 

Related to Deafness and Communicative 

Disorders, National Institutes of Health, HHS) 

mstockstill on DSK4VPTVN1PROD with NOTICES

Federal Register / Vol. 79, No. 235 / Monday, December 8, 2014 / Notices 72695 

Dated: December 2, 2014. 

Melanie J. Gray, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2014–28661 Filed 12–5–14; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HOUSING AND 

URBAN DEVELOPMENT 

[Docket No. FR–5826–N–01] 

Notice of HUD-Held Healthcare Loan 

Sale (HLS 2015–1) 

AGENCY: Office of the Assistant 

Secretary for Housing—Federal Housing 

Commissioner, HUD. 

ACTION: Notice of sale of a healthcare 

mortgage loan. 

SUMMARY: This notice announces HUD’s 

intention to sell an unsubsidized 

healthcare mortgage loan, without 

Federal Housing Administration (FHA) 

insurance, in a competitive auction 

(HLS 2015–1 or Loan Sale) on or about 

December 17, 2014. This notice also 

describes generally the bidding process 

for the sale and certain persons who are 

ineligible to bid. 

DATES: A Bidder’s Information Package 

(BIP) was made available on or about 

November 13, 2014. Bids for the loan 

must be submitted on the bid date of 

December 17, 2014 between certain 

specified hours. HUD anticipates that an 

award will be made on or before 

December 22, 2014. Closing is expected 

to take place between December 23, 

2014 and December 31, 2014. 

ADDRESSES: To become a qualified 

bidder and receive the BIP, prospective 

bidders must complete, execute, and 

submit a Confidentiality Agreement and 

a Qualification Statement acceptable to 

HUD. Both documents will be available 

on the HUD Web site at www.hud.gov/ 

fhaloansales. Please fax or email as well 

as mail executed original documents to 

JS Watkins Realty Partners, LLC: J.S. 

Watkins Realty Partners, LLC, c/o The 

Debt Exchange, 133 Federal Street, 10th 

Floor, Boston, MA 02111, Attention: 

HLS 2015–1 Sale Coordinator, Fax: 1– 

978–967–8607, Email: hls2015–1@

debtx.com. 

FOR FURTHER INFORMATION CONTACT: John 

Lucey, Director, Asset Sales Office, 

Room 3136, U.S. Department of Housing 

and Urban Development, 451 Seventh 

Street SW., Washington, DC 20410– 

8000; telephone 202–708–2625, 

extension 3927. Hearing- or speechimpaired individuals may call 202–708– 

4594 (TTY). These are not toll-free 

numbers. 

SUPPLEMENTARY INFORMATION: HUD 

announces its intention to sell, in HLS 

2015–1, an unsubsidized healthcare 

mortgage loan (Mortgage Loan) secured 

by a hospital (medical center) located in 

Texas. The Mortgage Loan is a nonperforming mortgage loan. The listing of 

the Mortgage Loan is included in the 

BIP. The Mortgage Loan will be sold 

without FHA insurance and with HUD 

servicing released. HUD will offer 

qualified bidders an opportunity to bid 

competitively on the Mortgage Loan. 

The Qualification Statement describes 

the entities/individuals that may be 

qualified to bid on the Mortgage Loan if 

they meet certain requirements as 

detailed in the Qualification Statement. 

Some entities/individuals must meet 

additional requirements in order to be 

qualified to bid, including but not 

limited to: (1) Any mortgagee/servicer 

who originated the Mortgage Loan; (2) a 

mortgagor, a healthcare operator, or 

member of the hospital Board of 

Directors with respect to any HUD 

insured or subsidized mortgage loan 

(excluding the Mortgage Loan being 

offered in the Loan Sale) who is 

currently in default, violation, or 

noncompliance with one or more of 

HUD’s requirements or business 

agreements; (3) a limited partner, 

nonmanaging member, investor and/or 

shareholder who owns a 1% or less 

interest in the Mortgage Loan, or in the 

project securing the Mortgage Loan; (4) 

and any of the aforementioned entities’/ 

individuals’ principals, affiliates, and 

assigns. Interested entities/individuals 

who fall into one of these categories 

should review the Qualification 

Statement to determine whether they 

may be eligible to qualify to submit a 

bid on the Mortgage Loan. Other 

entities/individuals not described 

herein may also be restricted from 

bidding on the Mortgage Loan, as fully 

detailed in the Qualification Statement. 

The Bidding Process 

The BIP describes in detail the 

procedure for bidding in HLS 2015–1. 

The BIP also includes a standardized 

non-negotiable loan sale agreement 

(Loan Sale Agreement). 

As part of its bid, each bidder must 

submit a minimum deposit of the 

greater of 10 percent of the total bid or 

$100,000. HUD will evaluate the bids 

submitted and determine the successful 

bid(s) in its sole and absolute discretion. 

If a bidder is successful, the bidder’s 

deposit will be non-refundable and will 

be applied toward the purchase price, 

with any amount beyond the purchase 

price being returned to the bidder. 

Deposits will be returned to 

unsuccessful bidders. Closings are 

expected to take place between 

December 23, 2014 and December 31, 

2014. 

These are the essential terms of sale. 

The Loan Sale Agreement, which is 

included in the BIP, contains additional 

terms and details. To ensure a 

competitive bidding process, the terms 

of the bidding process and the Loan Sale 

Agreement are not subject to 

negotiation. 

Due Diligence Review 

The BIP describes the due diligence 

process for reviewing loan files in HLS 

2015–1. Qualified bidders will be able 

to access loan information remotely via 

a high-speed Internet connection. 

Further information on performing due 

diligence review of the Mortgage Loans 

is provided in the BIP. 

Mortgage Loan Sale Policy 

HUD reserves the right to reject any 

and all bids, in whole or in part, 

without prejudice to HUD’s right to 

include the Mortgage Loan in a later 

sale. The Mortgage Loan will not be 

withdrawn after the Award Date except 

as is specifically provided for in the 

Loan Sale Agreement. 

This is a sale of an unsubsidized 

mortgage loan, pursuant to Section 

204(a) of the Departments of Veterans 

Affairs and Housing and Urban 

Development, and Independent 

Agencies Appropriations Act of 1997, 

(12 U.S.C. 1715z–11a(a)). 

Mortgage Loan Sale Procedure 

HUD selected a competitive sale as 

the method to sell the Mortgage Loan. 

This method of sale optimizes HUD’s 

return on the sale of this Mortgage Loan, 

affords the greatest opportunity for all 

qualified bidders to bid on the Mortgage 

Loan, and provides the quickest and 

most efficient vehicle for HUD to 

dispose of the Mortgage Loan. 

Bidder Eligibility 

In order to bid in the sale, a 

prospective bidder must complete, 

execute and submit both a 

Confidentiality Agreement and a 

Qualification Statement acceptable to 

HUD. The following individuals and 

entities are among those ineligible to bid 

on the Mortgage Loan being sold in HLS 

2015–1: 

1. A mortgagor or a member of a 

hospital Board of Directors, with respect 

to the Mortgage Loan being offered in 

the Loan Sale, or an Active Shareholder 

with respect to the Mortgage Loan as 

defined by paragraph E of the 

Qualification Statement, including any 

and all of their principals, affiliates, 

assigns, and family member(s); 

mstockstill on DSK4VPTVN1PROD with NOTICES